Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong
· Delayed Price · Currency is HKD 11.92
-0.18 (-1.49%)
Apr 29, 2026, 4:08 PM HKT
HKG:2096 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 733.17 | 714.76 | 930.87 | 1,507 | Upgrade
|
| Depreciation & Amortization | - | 300.79 | 291.51 | 268.66 | 234.39 | Upgrade
|
| Other Amortization | - | 36.86 | 18.09 | 14.99 | 17.42 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 1.5 | -791.92 | 10.57 | -402.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 28.47 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 266.25 | 744.82 | -113.11 | -697.19 | Upgrade
|
| Loss (Gain) on Equity Investments | - | -2.16 | -7.84 | -0.19 | 44.19 | Upgrade
|
| Stock-Based Compensation | - | 97.81 | 12.12 | 138.29 | 62.39 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -6.84 | -0.87 | -13.97 | 15.83 | Upgrade
|
| Other Operating Activities | - | 49.3 | 62.68 | 38.36 | -182.36 | Upgrade
|
| Change in Accounts Receivable | - | -94.47 | -322.9 | 86.24 | -545.2 | Upgrade
|
| Change in Inventory | - | -24.83 | -376.64 | -116.99 | -8.33 | Upgrade
|
| Change in Accounts Payable | - | - | - | - | 81.87 | Upgrade
|
| Change in Unearned Revenue | - | -15.43 | -10.24 | -14.26 | -30.34 | Upgrade
|
| Change in Other Net Operating Assets | - | 49.18 | -210.99 | 124.65 | -299.73 | Upgrade
|
| Operating Cash Flow | - | 1,391 | 151.05 | 1,354 | -201.97 | Upgrade
|
| Operating Cash Flow Growth | - | 820.98% | -88.84% | - | - | Upgrade
|
| Capital Expenditures | - | -356.97 | -483.18 | -342.82 | -209.49 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 50.09 | 118.31 | 0.27 | 5.91 | Upgrade
|
| Divestitures | - | 34.11 | 993.52 | - | 97.7 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -405.6 | -496.67 | -335.19 | - | Upgrade
|
| Investment in Securities | - | -502.98 | 793.29 | 479.5 | -1,091 | Upgrade
|
| Other Investing Activities | - | 131.26 | 162.54 | 266.54 | 761.71 | Upgrade
|
| Investing Cash Flow | - | -1,050 | 1,088 | 68.31 | -435.5 | Upgrade
|
| Long-Term Debt Issued | - | 1,253 | 1,216 | 916.93 | 1,027 | Upgrade
|
| Total Debt Issued | - | 1,253 | 1,216 | 916.93 | 1,027 | Upgrade
|
| Long-Term Debt Repaid | - | -1,505 | -1,367 | -1,233 | -2,505 | Upgrade
|
| Total Debt Repaid | - | -1,505 | -1,367 | -1,233 | -2,505 | Upgrade
|
| Net Debt Issued (Repaid) | - | -252.13 | -151.07 | -316.38 | -1,478 | Upgrade
|
| Repurchase of Common Stock | - | -687.99 | -289.07 | - | - | Upgrade
|
| Common Dividends Paid | - | -401.48 | -419.22 | -391.3 | -391.3 | Upgrade
|
| Other Financing Activities | - | 934.19 | -35.47 | -46.01 | 244.75 | Upgrade
|
| Financing Cash Flow | - | -407.4 | -894.83 | -753.68 | -1,625 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 2.29 | 4.83 | 15.12 | -35.1 | Upgrade
|
| Net Cash Flow | - | -64.09 | 348.85 | 683.85 | -2,297 | Upgrade
|
| Free Cash Flow | - | 1,034 | -332.13 | 1,011 | -411.46 | Upgrade
|
| Free Cash Flow Margin | - | 15.59% | -5.03% | 15.99% | -8.23% | Upgrade
|
| Free Cash Flow Per Share | - | 0.41 | -0.13 | 0.39 | -0.16 | Upgrade
|
| Cash Interest Paid | - | 30.79 | 35.47 | 29.98 | 70.85 | Upgrade
|
| Cash Income Tax Paid | - | 114.54 | 10.18 | -7.1 | 14.7 | Upgrade
|
| Levered Free Cash Flow | - | 453.05 | -1,045 | 175.48 | 438.89 | Upgrade
|
| Unlevered Free Cash Flow | - | 496.52 | -1,023 | 196.99 | 483.17 | Upgrade
|
| Change in Working Capital | - | -85.55 | -920.76 | 79.64 | -801.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.